As mentioned above, a full understanding of the mechanism of the inflammasome in kidney disease may help to comprehend the pathogenesis of renal disease and NLRP3, which may be a promising therapeutic target in CKD. This evidence concerns the gene NLRP3 and chronic kidney disease.